Qvanteq AG has developed a fast and simple method to screen materials used for medical devices with respect to their thrombus formation capacity. Respective work is normally done using whole human blood. For inquiries please contact the company.
Qvanteq AG has moved into new offices at the Technopark in Zürich.
Differential protein adsorption of surface treated Nitinol alloys regulates blood activation K Gegenschatz-Schmid, S Buzzi, J Grossmann, B Roschitzki, D Glück, A Zucker, M Ehrbar Recent research results were presented at the 2019 Annual Meeting of the Swiss Society for Biomaterials + Regenerative Medicine. Abstract: Stents were developed for overcoming heart attacks and strokes caused […]
Qvanteq completed ISO13485:2016 re-certification under the guidance of the notified body DEKRA.